A German study has found that FDG PET can differentiate between responders and nonresponders two weeks after the initiation of neoadjuvant chemotherapy for advanced adenocarcinoma of the esophagogastric junction.
Leah Young
Advertisement
Articles by Leah Young
Advertisement
Latest Updated Articles
- PET produces early measure of response to chemotherapy for esophagogastric junction cancer
Published: August 14th 2007 | Updated:
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Assessing the Potential Impact in Radiology for GE HealthCare’s Acquisition of Intelerad
2
Mammography Study: Can Slab Reconstruction Technology Reinvent Efficiency with DBT?
3
RSNA: CCTA Study Reveals Link Between Common Air Pollutants and Coronary Artery Stenosis
4
RSNA: Ultrasound Study Reveals Vascular Complications Associated with Cosmetic Fillers
5
